Immuron Limited operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Immuron Limited with three other
pharmaceutical manufacturers in Australasia:
Auscann Group Holdings Ltd
sales of 861,770.00 Australian Dollars [US$591,467.22 ]
(956,472.00 Australian Dollars [US$656,464.99 ]
ECS Botanics Holdings Ltd
(1,384.00 Australian Dollars [US$949.89 ]
During the year ended June of 2019, sales at
Immuron Limited were A$2.92 million (US$2.00 million).
decrease of 21.0%
versus 2018, when the company's sales were A$3.69 million.